Urgent National Drug Shortage

Posted in Latest News on October 16, 2017.

The Department of Health was alerted that Fresenius Kabi has Xylocaine with epinephrine presentations on shortage due to increased demand for the product and manufacturing delays and Pfizer has lidocaine with epinephrine presentations on shortage due to manufacturing delays.

You can read more about these shortages at:

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=860 (for lidocaine with epinephrine)

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=937 (for bupivacaine with epinephrine



More Latest News

Important notice regarding Rhopressa
February 12, 2019

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa. Continue reading


Florida Jurisprudence CE Requirement
February 11, 2019

The Board of Optometry voted to waive the 2-hour Florida Jurisprudence requirement for all out-of-state licensees for the current biennium only. Click Here for more information. Continue reading